Kinaset Therapeutics
Develops inhaled therapies for severe respiratory diseases
$103MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops inhaled therapies for severe respiratory diseases
Pitching Pictet Alternative Advisors? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room